866-997-4948(US-Canada Toll Free)

Global Nuclear Medicine Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 116 Pages

This report studies the global market size of Nuclear Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Nuclear Medicine in these regions.
This research report categorizes the global Nuclear Medicine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Nuclear Medicineor Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.
In 2017, the global Nuclear Medicine market size was 4590 million US$ and is forecast to 7580 million US in 2025, growing at a CAGR of 7.4% from 2018. The objectives of this study are to define, segment, and project the size of the Nuclear Medicine market based on company, product type, application and key regions.

The various contributors involved in the value chain of Nuclear Medicine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Nuclear Medicine include
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng

Market Size Split by Type
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Other
Market Size Split by Application
Diagnostic
Therapeutic

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Nuclear Medicine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Nuclear Medicine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Nuclear Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nuclear Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Nuclear Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Nuclear Medicine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Nuclear Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Nuclear Medicine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Nuclear Medicine Market Size Growth Rate by Type
1.4.2 Tc-99
1.4.3 I-123/131
1.4.4 In-111
1.4.5 Xe-133
1.4.6 Th-201
1.4.7 Ga-67
1.4.8 Other
1.5 Market by Application
1.5.1 Global Nuclear Medicine Market Size Growth Rate by Application
1.5.2 Diagnostic
1.5.3 Therapeutic
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Nuclear Medicine Market Size
2.1.1 Global Nuclear Medicine Revenue 2016-2025
2.1.2 Global Nuclear Medicine Sales 2016-2025
2.2 Nuclear Medicine Growth Rate by Regions
2.2.1 Global Nuclear Medicine Sales by Regions
2.2.2 Global Nuclear Medicine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Nuclear Medicine Sales by Manufacturers
3.1.1 Nuclear Medicine Sales by Manufacturers
3.1.2 Nuclear Medicine Sales Market Share by Manufacturers
3.1.3 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.2 Nuclear Medicine Revenue by Manufacturers
3.2.1 Nuclear Medicine Revenue by Manufacturers (2016-2018)
3.2.2 Nuclear Medicine Revenue Share by Manufacturers (2016-2018)
3.3 Nuclear Medicine Price by Manufacturers
3.4 Nuclear Medicine Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine Product Category
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Nuclear Medicine Sales by Type
4.2 Global Nuclear Medicine Revenue by Type
4.3 Nuclear Medicine Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Nuclear Medicine Breakdown Data by Application

6 North America
6.1 North America Nuclear Medicine by Countries
6.1.1 North America Nuclear Medicine Sales by Countries
6.1.2 North America Nuclear Medicine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Nuclear Medicine by Type
6.3 North America Nuclear Medicine by Application
6.4 North America Nuclear Medicine by Company

7 Europe
7.1 Europe Nuclear Medicine by Countries
7.1.1 Europe Nuclear Medicine Sales by Countries
7.1.2 Europe Nuclear Medicine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Nuclear Medicine by Type
7.3 Europe Nuclear Medicine by Application
7.4 Europe Nuclear Medicine by Company

8 Asia Pacific
8.1 Asia Pacific Nuclear Medicine by Countries
8.1.1 Asia Pacific Nuclear Medicine Sales by Countries
8.1.2 Asia Pacific Nuclear Medicine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Nuclear Medicine by Type
8.3 Asia Pacific Nuclear Medicine by Application
8.4 Asia Pacific Nuclear Medicine by Company

9 Central & South America
9.1 Central & South America Nuclear Medicine by Countries
9.1.1 Central & South America Nuclear Medicine Sales by Countries
9.1.2 Central & South America Nuclear Medicine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Nuclear Medicine by Type
9.3 Central & South America Nuclear Medicine by Application
9.4 Central & South America Nuclear Medicine by Company

10 Middle East and Africa
10.1 Middle East and Africa Nuclear Medicine by Countries
10.1.1 Middle East and Africa Nuclear Medicine Sales by Countries
10.1.2 Middle East and Africa Nuclear Medicine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Nuclear Medicine by Type
10.3 Middle East and Africa Nuclear Medicine by Application
10.4 Middle East and Africa Nuclear Medicine by Company

11 Company Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.1.4 Nuclear Medicine Product Description
11.1.5 Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.2.4 Nuclear Medicine Product Description
11.2.5 Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.3.4 Nuclear Medicine Product Description
11.3.5 Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.4.4 Nuclear Medicine Product Description
11.4.5 Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.5.4 Nuclear Medicine Product Description
11.5.5 Recent Development
11.6 Triad Isotopes
11.6.1 Triad Isotopes Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.6.4 Nuclear Medicine Product Description
11.6.5 Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.7.4 Nuclear Medicine Product Description
11.7.5 Recent Development
11.8 Jubilant Pharma
11.8.1 Jubilant Pharma Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.8.4 Nuclear Medicine Product Description
11.8.5 Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.9.4 Nuclear Medicine Product Description
11.9.5 Recent Development
11.10 SIEMENS
11.10.1 SIEMENS Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Nuclear Medicine
11.10.4 Nuclear Medicine Product Description
11.10.5 Recent Development
11.11 China Isotope & Radiation
11.12 Dongcheng

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Nuclear Medicine Raw Material
13.1.2 Nuclear Medicine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Nuclear Medicine
Figure Global Nuclear Medicine Production (M Dose) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Nuclear Medicine Production Market Share by Types (Product Category) in 2017
Figure Tc-99 Product Picture
Table Major Manufacturers of Tc-99
Figure I-123/131 Product Picture
Table Major Manufacturers of I-123/131
Figure In-111 Product Picture
Table Major Manufacturers of In-111
Figure Xe-133 Product Picture
Table Major Manufacturers of Xe-133
Figure Th-201 Product Picture
Table Major Manufacturers of Th-201
Figure Ga-67 Product Picture
Table Major Manufacturers of Ga-67
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Nuclear Medicine Market Size Growth Rate by Application 2018-2025 (M Dose)
Figure Diagnostic
Figure Therapeutic
Figure Nuclear Medicine Report Years Considered
Figure Global Nuclear Medicine Market Size 2016-2025 (Million US$)
Figure Global Nuclear Medicine Sales 2016-2025 (M Dose)
Table Global Nuclear Medicine Market Size by Regions 2016-2025 (M Dose) & (Million US$)
Table Global Nuclear Medicine Sales by Regions 2016-2025 (M Dose)
Table Global Nuclear Medicine Sales Market Share by Regions 2016-2025
Figure Global Nuclear Medicine Sales Market Share by Regions 2016-2025
Figure 2017 Global Nuclear Medicine Sales Market Share by Regions
Table Global Nuclear Medicine Revenue by Regions 2016-2025 (Million US$)
Table Global Nuclear Medicine Revenue Market Share by Regions 2016-2025
Figure Global Nuclear Medicine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Nuclear Medicine Revenue Market Share by Regions
Table Global Nuclear Medicine Sales by Manufacturers (2016-2018) (M Dose)
Table Global Nuclear Medicine Sales Share by Manufacturers (2016-2018)
Figure Global Nuclear Medicine Sales Share by Manufacturers in 2017
Table Nuclear Medicine Revenue by Manufacturers (2016-2018) (Million US$)
Table Nuclear Medicine Revenue Share by Manufacturers (2016-2018)
Figure Nuclear Medicine Value Share by Manufacturers in 2017
Table Global Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Nuclear Medicine Price (2016-2018) (USD/Dose)
Table Nuclear Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Nuclear Medicine Product Category
Table Date of International Manufacturers Enter into Nuclear Medicine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Nuclear Medicine Sales by Type (2016-2025) (M Dose)
Table Global Nuclear Medicine Sales Share by Type (2016-2025)
Figure Global Nuclear Medicine Sales Market Share by Type (2016-2025)
Figure Global Nuclear Medicine Sales Market Share by Type in 2017
Table Global Nuclear Medicine Revenue by Type (2016-2025) (Million US$)
Table Global Nuclear Medicine Revenue Share by Type (2016-2025)
Figure Global Nuclear Medicine Revenue Market Share by Type (2016-2025)
Figure Global Nuclear Medicine Revenue Market Share by Type in 2017
Table Nuclear Medicine Price by Type 2013-2018 (USD/Dose)
Table Global Nuclear Medicine Sales by Application (2016-2025) (M Dose)
Table Global Nuclear Medicine Sales Share by Application (2016-2025)
Figure Global Sales Nuclear Medicine Market Share by Application (2016-2025)
Figure Global Sales Nuclear Medicine Market Share by Application (2016-2025)
Figure North America Nuclear Medicine Sales Growth Rate 2016-2025 (M Dose)
Figure North America Nuclear Medicine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Nuclear Medicine Sales by Countries (2016-2025) (M Dose)
Table North America Nuclear Medicine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Nuclear Medicine Sales Market Share by Countries
Table North America Nuclear Medicine Revenue by Countries (2016-2025) (Million US$)
Table North America Nuclear Medicine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Nuclear Medicine Revenue Market Share by Countries
Figure United States Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure United States Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Canada Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Mexico Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Nuclear Medicine Sales by Type (2016-2025) (M Dose)
Table North America Nuclear Medicine Sales Market Share by Type (2016-2025)
Figure 2017 North America Nuclear Medicine Market Share by Type
Table North America Nuclear Medicine Sales by Application (2016-2025) (M Dose)
Table North America Nuclear Medicine Sales Market Share by Application (2016-2025)
Figure 2017 North America Nuclear Medicine Market Share by Application
Table North America Nuclear Medicine Sales by Company (2016-2018) (M Dose)
Table North America Nuclear Medicine Sales Market Share by Company (2016-2018)
Figure North America Nuclear Medicine Sales Market Share by Company in 2017
Figure Europe Nuclear Medicine Sales Growth Rate 2016-2025 (M Dose)
Figure Europe Nuclear Medicine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Nuclear Medicine Sales by Countries (2016-2025) (M Dose)
Table Europe Nuclear Medicine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Nuclear Medicine Sales Market Share by Countries
Table Europe Nuclear Medicine Revenue by Countries (2016-2025) (Million US$)
Table Europe Nuclear Medicine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Nuclear Medicine Revenue Market Share by Countries
Figure Germany Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Germany Nuclear Medicine Revenue Growth Rate (2016-2025) (M Dose)
Figure France Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure France Nuclear Medicine Revenue Growth Rate (2016-2025) (M Dose)
Figure UK Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure UK Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Italy Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Russia Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Nuclear Medicine Sales by Type (2016-2025) (M Dose)
Table Europe Nuclear Medicine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Nuclear Medicine Market Share by Type
Table Europe Nuclear Medicine Sales by Application (2016-2025) (M Dose)
Table Europe Nuclear Medicine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Nuclear Medicine Market Share by Application
Table Europe Nuclear Medicine Sales by Company (2016-2018) (M Dose)
Table Europe Nuclear Medicine Sales Market Share by Company (2016-2018)
Figure Europe Nuclear Medicine Sales Market Share by Company in 2017
Figure Asia Pacific Nuclear Medicine Sales Growth Rate 2016-2025 (M Dose)
Figure Asia Pacific Nuclear Medicine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Nuclear Medicine Sales by Countries (2016-2025) (M Dose)
Table Asia Pacific Nuclear Medicine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Nuclear Medicine Sales Market Share by Countries
Table Asia Pacific Nuclear Medicine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Nuclear Medicine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Nuclear Medicine Revenue Market Share by Countries
Figure China Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure China Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Japan Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Korea Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure India Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Australia Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Indonesia Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Malaysia Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Philippines Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Thailand Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Vietnam Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Singapore Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Nuclear Medicine Sales by Type (2016-2025) (M Dose)
Table Asia Pacific Nuclear Medicine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Nuclear Medicine Market Share by Type
Table Asia Pacific Nuclear Medicine Sales by Application (2016-2025) (M Dose)
Table Asia Pacific Nuclear Medicine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Nuclear Medicine Market Share by Application
Table Asia Pacific Nuclear Medicine Sales by Company (2016-2018) (M Dose)
Table Asia Pacific Nuclear Medicine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Nuclear Medicine Sales Market Share by Company in 2017
Figure Central & South America Nuclear Medicine Sales Growth Rate 2016-2025 (M Dose)
Figure Central & South America Nuclear Medicine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Nuclear Medicine Sales by Countries (2016-2025) (M Dose)
Table Central & South America Nuclear Medicine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Nuclear Medicine Sales Market Share by Countries
Table Central & South America Nuclear Medicine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Nuclear Medicine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Nuclear Medicine Revenue Market Share by Countries
Figure Brazil Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Brazil Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Argentina Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Nuclear Medicine Sales by Type (2016-2025) (M Dose)
Table Central & South America Nuclear Medicine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Nuclear Medicine Market Share by Type
Table Central & South America Nuclear Medicine Sales by Application (2016-2025) (M Dose)
Table Central & South America Nuclear Medicine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Nuclear Medicine Market Share by Application
Table Central & South America Nuclear Medicine Sales by Company (2016-2018) (M Dose)
Table Central & South America Nuclear Medicine Sales Market Share by Company (2016-2018)
Figure Central & South America Nuclear Medicine Sales Market Share by Company in 2017
Figure Middle East and Africa Nuclear Medicine Sales Growth Rate 2016-2025 (M Dose)
Figure Middle East and Africa Nuclear Medicine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Nuclear Medicine Sales by Countries (2016-2025) (M Dose)
Table Middle East and Africa Nuclear Medicine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Nuclear Medicine Sales Market Share by Countries
Table Middle East and Africa Nuclear Medicine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Nuclear Medicine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Nuclear Medicine Revenue Market Share by Countries
Figure GCC Countries Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure GCC Countries Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Turkey Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure Egypt Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Nuclear Medicine Sales Growth Rate (2016-2025) (M Dose)
Figure South Africa Nuclear Medicine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Nuclear Medicine Sales by Type (2016-2025) (M Dose)
Table Middle East and Africa Nuclear Medicine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Nuclear Medicine Market Share by Type
Table Middle East and Africa Nuclear Medicine Sales by Application (2016-2025) (M Dose)
Table Middle East and Africa Nuclear Medicine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Nuclear Medicine Market Share by Application
Table Middle East and Africa Nuclear Medicine Sales by Company (2016-2018) (M Dose)
Table Middle East and Africa Nuclear Medicine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Nuclear Medicine Sales Market Share by Company in 2017
Table GE Healthcare Company Details
Table GE Healthcare Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table GE Healthcare Recent Development
Table Bracco Imaging Company Details
Table Bracco Imaging Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Bracco Imaging Recent Development
Table Mallinckrodt Company Details
Table Mallinckrodt Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Mallinckrodt Recent Development
Table Lantheus Medical Imaging Company Details
Table Lantheus Medical Imaging Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Lantheus Medical Imaging Recent Development
Table Bayer Company Details
Table Bayer Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Bayer Recent Development
Table Triad Isotopes Company Details
Table Triad Isotopes Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Triad Isotopes Recent Development
Table Nordion Company Details
Table Nordion Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Nordion Recent Development
Table Jubilant Pharma Company Details
Table Jubilant Pharma Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Jubilant Pharma Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table Eli Lilly Recent Development
Table SIEMENS Company Details
Table SIEMENS Nuclear Medicine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
Table SIEMENS Recent Development
Table China Isotope & Radiation Company Details
Table Dongcheng Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Nuclear Medicine Value Chain
Table Typical Suppliers of Key Nuclear Medicine Raw Material
Table Nuclear Medicine Customers List
Table Nuclear Medicine Sales Channels
Table Nuclear Medicine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *